CRESCENT BIOPHARMA, INC. (CBIO) Total liabilities 2013–2025
CRESCENT BIOPHARMA, INC. (CBIO) total liabilities at each fiscal year-end, per SEC filings.
$37.3MFY2025 · since FY2013: $2.4M → $37.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $37.3M | — |
| FY2023 | $6.9M | -22.3% |
| FY2022 | $8.9M | -30.3% |
| FY2021 | $12.7M | -12.8% |
| FY2020 | $14.6M | — |
| FY2016 | $7.1M | -11.3% |
| FY2015 | $8.0M | +23.7% |
| FY2014 | $6.5M | +171.9% |
| FY2013 | $2.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice